Left and right ventricular longitudinal systolic function following aortic valve replacement in the PARTNER 2 trial and registry.
Iria SilvaJulien TernacleRebecca T HahnMohamed Salah-AnnabiAbdellaziz DahouLaura KrapfErwan SalaunEzequiel GuzzettiKe XuMarie-Annick ClavelMathieu BernierJonathan BeaudoinPaul C CremerWael JaberLeonardo RodriguezFederico M AschNeil J WeismannJeroen BaxNina AjmoneMaria C AluFaouzi KallelMichael J MackJohn G WebbSamir R KapadiaRaj R MakkarSusheel KodaliHoward C HerrmannVinod ThouraniMartin B LeonPhillippe PibarotPublished in: European heart journal. Cardiovascular Imaging (2024)
SAVR but not TAVR was associated with a marked deterioration in RV longitudinal systolic function and RV-PA coupling. Lower TAPSE and RV-PA coupling at 30 days were associated with inferior clinical outcomes at 5 years. In patients with LVEF < 50%, TAVR was associated with superior 5-year outcomes.
Keyphrases
- aortic valve replacement
- aortic stenosis
- mycobacterium tuberculosis
- aortic valve
- left ventricular
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- blood pressure
- ejection fraction
- heart failure
- room temperature
- cross sectional
- clinical trial
- study protocol
- randomized controlled trial
- phase iii
- phase ii
- metabolic syndrome
- skeletal muscle
- atrial fibrillation
- open label
- hepatitis c virus
- electron transfer
- hiv infected
- insulin resistance
- glycemic control
- human immunodeficiency virus
- antiretroviral therapy